Scientists test new drug combo in prostate cancer before surgery

NCT ID NCT05938270

Summary

This study aims to understand the biological effects of two investigational drugs, saruparib and darolutamide, given alone and in combination to men newly diagnosed with prostate cancer who are scheduled for surgery. The main goal is to see how these treatments change specific markers in the tumor tissue and to check their safety. It is an early-phase study enrolling about 120 participants to gather initial data.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Research Site

    RECRUITING

    Providence, Rhode Island, 02903, United States

  • Research Site

    RECRUITING

    Melbourne, VIC 3000, Australia

  • Research Site

    RECRUITING

    South Brisbane, 4101, Australia

  • Research Site

    RECRUITING

    Vancouver, British Columbia, V5Z 1M9, Canada

  • Research Site

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Research Site

    RECRUITING

    Québec, Quebec, G1J 1Z4, Canada

  • Research Site

    RECRUITING

    Amsterdam, 1066CX, Netherlands

  • Research Site

    RECRUITING

    Nijmegen, 6525 GA, Netherlands

  • Research Site

    RECRUITING

    Barcelona, 08036, Spain

  • Research Site

    RECRUITING

    Barcelona, 8035, Spain

  • Research Site

    RECRUITING

    Madrid, 28041, Spain

  • Research Site

    RECRUITING

    Valencia, 46009, Spain

  • Research Site

    WITHDRAWN

    Ankara, 06100, Turkey (Türkiye)

  • Research Site

    WITHDRAWN

    Ankara, 6200, Turkey (Türkiye)

  • Research Site

    WITHDRAWN

    Istanbul, 34010, Turkey (Türkiye)

  • Research Site

    RECRUITING

    Cambridge, CB2 0QQ, United Kingdom

  • Research Site

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • Research Site

    RECRUITING

    Newcastle upon Tyne, NE7 7AF, United Kingdom

Conditions

Explore the condition pages connected to this study.